301333 fundamentals
An in-depth look to R&G PHARMASTUDIES operating, investing, and financing activities
301333 free cash flow for Q4 24 is 47.43 M CNY. For 2024, 301333 free cash flow was 157.73 M CNY and operating cash flow was 177.71 M CNY.
Q4 '19
Q3 '20
Q4 '20
Q2 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q4 '19
Q3 '20
Q4 '20
Q2 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM